Brian Amos, Ph.D. Senior Counsel
| Direct | 212 336 8123 |
|---|---|
| Main | 212 336 8000 |
| Fax | 212 336 8001 |
E-mail
V-CardBrian J. Amos, Ph.D. is a former research neuroscientist who represents universities, research institutions and corporations in the preparation and prosecution of patent applications worldwide, predominantly in the fields of biotechnology, medical therapeutics and pharmaceuticals. He works closely with scientists, in-house counsel and Technology Transfer Offices to identify and inventory new patentable technologies; protect discoveries through patents; and commercialize intellectual property through licensing and development arrangements with other business entities.
Dr. Amos’ specific areas of patent procurement include artificial intelligence-based technologies, diagnostic technologies, antibodies and fusion proteins, engineered immune therapeutics and targeted therapies, immune checkpoint interventions, recombinant live vaccines, vaccine enhancers, cancer therapies, nucleic acid sequencing technologies, siRNAs, antisense oligonucleotides, stem cell-based therapies, cardiac treatments, neurological treatments, cellular delivery agents, nucleic acid-based nanotechnologies, small molecules, pharmaceutical formulations, complete syntheses of natural products, EEG-based methods and medical devices.
Dr. Amos has published articles in Nature Biotechnology and Oxford University Press on patent law issues and has been a webinar presenter to Tech Transfer professionals and other attorneys on subjects such as patentable subject matter in diagnostics and Bayh-Dole Act compliance.
Because Dr. Amos works with patent litigators, his approach to patent prosecution is keenly formed by knowledge of how a patent may be challenged. In addition to having broad experience in all aspects of U.S. patent procurement, including reissue, reexamination and interference practice, he has extensive experience in international prosecution including before the European, Japanese, Chinese, Canadian and Australian patent offices, as well as European opposition practice. He coordinates U.S. and foreign prosecution with the goal of obtaining the most effective and strongest coverage available, with a particular focus on the most lucrative markets. He works with clients on the fast timeline of European Opposition Proceedings when, once filed or issued, a window is briefly open to defend patents or invalidate others.
Dr. Amos received a Ph.D. in Neuroscience from the RFHSM, which is part of University College London, and graduated magna cum laude from New York Law School in July 2003. He is admitted to the New York State Bar and is registered to practice before the U.S. Patent and Trademark Office.
Published Articles
-
US Appellate Court boosts ‘diagnose and treat’ claims
-
Exploring Viability Of 'Diagnose And Treat' Method Claims
ARELaw Alerts
-
ARE Patent Law Alert:
Federal Circuit Finds Method of Treatment Claims Patent-Eligible, Not Directed to Natural Law
-
ARE Patent Law Alert:
USPTO GUIDANCE ON SUBJECT MATTER ELIGIBILITY OF METHOD OF TREATMENT CLAIMS
In The Press
-
Charles Macedo to Introduce Keynote Speaker at 2020 AUTM Annual Meeting
-
Amster Rothstein & Ebenstein Promotes Brian Amos to Senior Counsel
Bar Admissions
- New York, 2003
- U.S. Patent and Trademark Office
Education
- J.D., New York Law School, 2003 (Magna Cum Laude)
- Ph.D. in Neuroscience, RFHSM, University of London, 1994
- B.Sc. (Hons.) in Physiology, UCL, 1990
Professional Associations & Memberships
- New York Intellectual Property Lawyers Association
- American Intellectual Property Law Association
- American Chemical Society (ACS)
- Association of University Technology Managers (AUTM)